Evidence map›Paper›PMID 23904115›Full record

ArticleInternational journal of cancer2014

Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer.

M Constanza Camargo, Chihaya Koriyama, Keitaro Matsuo, Woo-Ho Kim, Roberto Herrera-Goepfert, Linda M Liao, Eurgast-EPIC Group, Jun Yu, Gabriel Carrasquilla, Joseph J Y Sung and 12 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in International journal of cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Dose-response association between cigarette smoking and gastric cancer risk: a systematic review and meta-analysis.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Pooled it
  2. Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Pooled it
  3. Pooled it
  4. Viral oncogenesis in cancer: from mechanisms to therapeutics.Signal transduction and targeted therapy · 2025
    Review
  5. Gastric Cancer Genetics and Its Implications for Diagnosis, Prognosis, and Treatment of the Disease.The Korean journal of helicobacter and upper gastrointestinal research · 2024
    Review
  6. Article
  7. Sex-dependent different clinicopathological characterization of Epstein-Barr virus-associated gastric carcinoma: a large-scale study.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Article
  8. Review
  9. Real-World Situation of Eradication Regimens and Risk Factors forClinical and experimental gastroenterology · 2024
    Article
  10. [Infectious Gastric Diseases Other thanThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Viral Pathogens in Oesophageal and Gastric Cancer.Pathogens (Basel, Switzerland) · 2022
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 10 institutions in 8 countries.

M Constanza CamargoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Chihaya Koriyama
Keitaro Matsuo
Woo-Ho Kim
Roberto Herrera-Goepfert
Linda M Liao
Eurgast-EPIC Group
Jun Yu
Gabriel Carrasquilla
Joseph J Y Sung
Isabel Alvarado-Cabrero
Jolanta Lissowska
Fernando Meneses-Gonzalez
Yashushi Yatabe
Ti Ding
Nan Hu
Philip R Taylor
Douglas R Morgan
Margaret L Gulley
Javier Torres
Suminori Akiba
Charles S Rabkin
National Cancer Institute · USChinese University of Hong Kong · HKKagoshima University · JPUniversity of North Carolina at Chapel Hill · USMexican Social Security Institute · MXSecretaria de Salud · MXShanxi Provincial Cancer Hospital · CNInstituto Nacional de Cancerología · MXKyushu University · JPSeoul National University · KR

Funding

PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBERT S. SANDLER · 1985 to 2026
$30.5M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Molecular mechanisms of infection-related cancerZIACP010212 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ENGELS, ERIC A · 2010 to 2025
$4.6M
Gastric Cancer Epidemiology Initiative in Central AmericaK07CA125588 · NCI · VANDERBILT UNIVERSITY · PI MORGAN, DOUGLAS · 2007 to 2011
$680k
Intramural NIH HHS Z99 CA999999NCI NIH HHS CA125588NCI NIH HHS K07 CA125588NIDDK NIH HHS P30 DK034987NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

Helicobacter pylori is the primary cause of gastric cancer. However, monoclonal Epstein-Barr virus (EBV) nucleic acid is also present in up to 10% of these tumors worldwide. EBV prevalence is increased with male sex, nonantral localization and surgically disrupted anatomy. To further examine associations between EBV and gastric cancer, we organized an international consortium of 11 studies with tumor EBV status assessed by in situ hybridization. We pooled individual-level data on 2,648 gastric cancer patients, including 184 (7%) with EBV-positive cancers; all studies had information on cigarette use (64% smokers) and nine had data on alcohol (57% drinkers). We compared patients with EBV-positive and EBV-negative tumors to evaluate smoking and alcohol interactions with EBV status. To account for within-population clustering, multilevel logistic regression models were used to estimate interaction odds ratios (OR) adjusted for distributions of sex (72% male), age (mean 59 years), tumor histology (56% Lauren intestinal-type), anatomic subsite (61% noncardia) and year of diagnosis (1983-2012). In unadjusted analyses, the OR of EBV positivity with smoking was 2.2 [95% confidence interval (CI) 1.6-3.2]. The OR was attenuated to 1.5 (95% CI 1.01-2.3) by adjustment for the possible confounders. There was no significant interaction of EBV status with alcohol drinking (crude OR 1.4; adjusted OR 1.0). Our data indicate the smoking association with gastric cancer is stronger for EBV-positive than EBV-negative tumors. Conversely, the null association with alcohol does not vary by EBV status. Distinct epidemiologic characteristics of EBV-positive cancer further implicate the virus as a cofactor in gastric carcinogenesis.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overAlcohol DrinkingCase-Control StudiesEpstein-Barr Virus InfectionsFemaleFollow-Up StudiesHerpesvirus 4, HumanHumansMaleMiddle AgedNeoplasm StagingOdds RatioPrognosisalcoholEBVgastric cancerpooled-analysissmoking

Identifiers

PMID23904115
PMCPMC3961829
OpenAlexW1662045052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.